Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Lilly, CureVac Partner on RNA Cancer Drugs in $1.8B Deal

Drug maker Eli Lilly and Company and biotechnology company CureVac AG agreed to develop a series of cancer immunotherapies based on CureVac’s messenger RNA technology. . . . → Read More: Lilly, CureVac Partner on RNA Cancer Drugs in $1.8B Deal

Flashback: Drug Pricing Reform Even Big Pharma Might Like

Science & Enterprise is taking a break From 2 to 13 October. Until then, we will re-run some of our recent special reports. Our regular posts will return on 16 October.

(TBIT/Pixabay)

2 May 2016. At a press event in Washington, D.C. last week, Representative Lloyd Doggett of Texas, a champion of lower prescription . . . → Read More: Flashback: Drug Pricing Reform Even Big Pharma Might Like

Infographic – Europe’s High Value Tech Companies

Our friends at Statista this week collected the top European technology companies in market value, displayed in this chart. . . . → Read More: Infographic – Europe’s High Value Tech Companies

Geisinger, Pharmas Partner on Diabetes Model

An alliance between the Geisinger Health System and two pharmaceutical companies is developing a computer model to predict long-term health risks of patients with type 2 diabetes. . . . → Read More: Geisinger, Pharmas Partner on Diabetes Model

Stem Cells Shown to Heal Chronic Leg Wounds

Experimental treatments using patients’ own stem cells were shown in a pilot test to heal painful chronic wounds on their legs and feet. . . . → Read More: Stem Cells Shown to Heal Chronic Leg Wounds

Synthetic DNA Start-Up Raises $13M in Early Funds

A company producing synthesized DNA for medical and other biotechnology applications is raising €11 million ($US 13 million) in its first venture funding round. . . . → Read More: Synthetic DNA Start-Up Raises $13M in Early Funds

Trial Shows Antibody Effective Against Asthma

Results from a large-scale clinical trial show a synthetic antibody, when added to standard treatments, reduces asthma attacks and improves lung functioning. . . . → Read More: Trial Shows Antibody Effective Against Asthma

Risks of E-Cigarette Use, Ingredients Highlighted

Several sessions at a scientific meeting on respiratory diseases report on effects of electronic cigarettes on people’s health, including those who also smoke conventional cigarettes. . . . → Read More: Risks of E-Cigarette Use, Ingredients Highlighted

Trial Underway Testing Alzheimer’s-Schizophrenia Drug

A new clinical trial began in the U.K. in a test of an experimental drug to treat schizophrenia associated with Alzheimer’s disease. . . . → Read More: Trial Underway Testing Alzheimer’s-Schizophrenia Drug

Trial Shows Smartphone App Finds More Heart Disease

Results from a clinical trial show an electrocardiogram app on a smartphone detects more cases of irregular heart beats than routine office visits. . . . → Read More: Trial Shows Smartphone App Finds More Heart Disease